HappeningToo topic
Rivaroxaban reports
Browse community reports connected to Rivaroxaban. These reports can show that other people are describing similar experiences, but they do not prove that Rivaroxaban caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
32 problems
Abdominal Discomfort while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and abdominal discomfort appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and abdominal pain upper appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and abdominal pain appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and alopecia appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and anxiety appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and back pain appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and constipation appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and cough appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and decreased appetite appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and dehydration appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and diarrhea appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and dizziness appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and fatigue appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and feeling abnormal appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and headache appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and hypotension appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and insomnia appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and itching appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and malaise appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and muscle spasms appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and myalgia appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and nausea appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and pain appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and palpitations appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and peripheral swelling appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and rash appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and shortness of breath appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and sleepiness appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and vomiting appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and weakness appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and weight decreased appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Rivaroxaban
FDA FAERS contains adverse-event reports in which Rivaroxaban and weight increased appear together. This does not establish that Rivaroxaban caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →